
|
|
|
Health Science News
|
|
Today's health science headlines from the sources selected by our team:
|
|
Study: No Proven Morning Sickness Treatments
|
Treatments for morning sickness are plentiful, but the evidence that any of these treatments work is limited, according to a new review. Treatments for morning sickness are plentiful, but the evidence that any of these treatments work is limited, according to a new review.
|
|
|
|
Cholesterol-Lowering Drugs May Cut RA Risk
|
People who take cholesterol-lowering statin drugs to reduce heart disease risk may also be cutting their risk for developing the painful inflammatory joint disease rheumatoid arthritis. People who take cholesterol-lowering statin drugs to reduce heart disease risk may also be cutting their risk for developing the painful inflammatory joint disease rheumatoid arthritis.
|
|
|
|
Vitamin B 'puts off Alzheimer's'
|
|
High doses of B vitamins may slow the rate of brain shrinkage in older people experiencing warning signs of Alzheimer's disease, a study says.
|
|
|
|
NHS IT costs to be cut by £700m
|
|
The government has announced £700m of savings in the national IT programme for the NHS in England, cutting the overall cost to £11.4bn.
|
|
|
|
NIH-funded studies aim to prevent, treat childhood obesity
|
|
(NIH/National Heart, Lung and Blood Institute) The National Institutes of Health is launching two major research efforts, totaling $72.5 million, to examine ways to curtail the nation's childhood obesity epidemic. One will study long-term approaches to prevent or treat childhood obesity, and the other will examine community efforts to reduce childhood obesity rates.
|
|
|
|
Romantic partner may play role in reducing vulvovaginal pain
|
|
(University of Montreal) An investigation published in the Journal of Sexual Medicine has found that male partners who express greater support, attention and sympathy to women's chronic vulvovaginal pain may trigger more pain, but also increase sexual satisfaction in female partners.
|
|
|
|
23rd ECNP Congress: Europe's largest scientific meeting on mental health
|
|
(European College of Neuropsychopharmacology) The 23rd Congress of the European College of Neuropsychopharmacology covered a wide variety of issues of critical public health concern, such as depression, schizophrenia, addiction, chronopsychiatry and neurodegenerative disorders, including multiple sclerosis, Parkinson's and Alzheimer's disease. The program specifically emphasized the translation of new knowledge on fundamental disease mechanisms into clinical practice, paving the way for improved pharmacological and non-drug treatments for the prevention and treatment of all mental disorders and disorders of the brain in general.
|
|
|
powered by zFeeder
|
|

The top 5 resources selected by our team for health science news coverage:
Cancer Resource
Mesothelioma is a rare asbestos cancer caused by previous exposure to asbestos material.
Exposure was common among industrial and shipyard laborers. Find out more by visiting Mesothelioma.com today.
|